The present invention relates generally to medical devices and methods. More specifically, the present invention relates to ultrasound catheter devices and methods for treating occlusive intravascular lesions.
Catheters employing various types of ultrasound transmitting members have been successfully used to ablate or otherwise disrupt obstructions in blood vessels. Specifically, ablation of atherosclerotic plaque or thromboembolic obstructions from peripheral blood vessels such as the femoral arteries has been particularly successful. Various ultrasonic catheter devices have been developed for use in ablating or otherwise removing obstructive material from blood vessels. For example, U.S. Pat. Nos. 5,267,954 and 5,380,274, issued to an inventor of the present invention and hereby incorporated by reference, describe ultrasound catheter devices for removing occlusions. Other examples of ultrasonic ablation devices for removing obstructions from blood vessels include those described in U.S. Pat. Nos. 3,433,226 (Boyd), 3,823,717 (Pohlman, et al.), 4,808,153 (Parisi), 4,936,281 (Stasz), 3,565,062 (Kuris), 4,924,863 (Sterzer), 4,870,953 (Don Michael, et al), and 4,920,954 (Alliger, et al.), as well as other patent publications WO87-05739 (Cooper), WO89-06515 (Bernstein, et al.), WO90-0130 (Sonic Needle Corp.), EP, EP316789 (Don Michael, et al.), DE3,821,836 (Schubert) and DE2438648 (Pohlman). While many ultrasound catheters have been developed, however, improvements are still being pursued.
Typically, an ultrasonic catheter system for ablating occlusive material includes three basic components: an ultrasound generator, an ultrasound transducer, and an ultrasound catheter. The generator converts line power into a high frequency current that is delivered to the transducer. The transducer contains piezoelectric crystals which, when excited by the high frequency current, expand and contract at high frequency. These small, high-frequency expansions and contractions have both longitudinal and transverse components (relative to an axis of the transducer and the catheter), which are amplified by the transducer horn into vibrational energy. The vibrations are then transmitted from the transducer through the ultrasound catheter via an ultrasound transmission member (or wire) running longitudinally through the catheter. The transmission member transmits the vibrational energy to the distal end of the catheter where the energy is used to ablate or otherwise disrupt a vascular obstruction.
To effectively reach various sites for treatment of intravascular occlusions, ultrasound catheters of the type described above typically have lengths of about 150 cm or longer. To permit the advancement of such ultrasound catheters through small and/or tortuous blood vessels such as the aortic arch, coronary vessels, and peripheral vasculature of the lower extremities, the catheters (and their respective ultrasound transmission wires) must typically be sufficiently small and flexible. Due to attenuation of ultrasound energy along the long, thin, ultrasound transmission wire, a sufficient amount of vibrational energy must be applied at the proximal end of the wire to provide a desired amount of energy at the distal end.
An ultrasound transmission wire is usually coupled at its proximal end with the transducer by means of a sonic connector. The sonic connector typically has a significantly larger diameter than that of the ultrasound transmission member, the difference in diameters helping to amplify the vibrational energy being transmitted from the transducer to the transmission wire. This amplification of vibrations, however, creates stress and heat in the transmission wire in an area adjacent its connection with the sonic connector. Stress and heat generated by these amplified vibrations (especially transverse vibrations) significantly reduce the usable life of the ultrasound transmission wire and may cause its premature breakage at or near the point of contact with the sonic connector.
Efforts have been made to reduce transverse vibrations somewhere along the length of an ultrasound transmission member. For example, U.S. Pat. Nos. 5,382,228 and 6,494,891, both of which issued to an inventor of the present invention and are hereby incorporated by reference, describe mechanisms for absorbing transverse motion of an ultrasound transmission wire. Currently available devices and devices described in the above patents, however, to not reduce stress and/or heat in an ultrasound transmission wire at or near its point of contact with a sonic connector as much as may be desired. As just discussed, this proximal area of the transmission wire may be one of the most vulnerable areas due to its exposure to amplified vibrational energy from the sonic connector.
Therefore, a need exists for an improved ultrasound catheter device and method that provides ablation or disruption of vascular occlusions. Ideally, the ultrasound catheter would include means for reducing heat in the ultrasound transmission wire component of the catheter at or near its coupling with the sonic connector component. Alternatively or additionally, it would also be ideal if transverse vibrations and stress were reduced in a proximal portion of the transmission wire. Such catheter devices would ideally be sufficiently thin and flexible to be advanced through narrow, tortuous vasculature, such as the coronary vasculature, while also being configured to enhance the usable life of the ultrasound transmission wire. At least some of these objectives will be met by the present invention.
Ultrasound catheter devices and methods of the present invention generally provide for ablation and/or disruption of vascular occlusions. An ultrasound transmission member, such as a wire, transmits vibrational energy from an ultrasound transducer to a distal head of the catheter to disrupt vascular occlusions. At least one absorber member is disposed on or around the ultrasound transmission wire at a location adjacent the sonic connector of the catheter. The absorber member absorbs heat, vibrations, and/or the like from the ultrasound transmission wire at or near the area where the transmission wire is coupled with the sonic connector. The absorptive function typically slows the process of wear and tear on the transmission wire, thus extending the useful life of the ultrasound catheter.
In one aspect of the invention, an ultrasound catheter for disrupting occlusions in blood vessels comprises: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body; a sonic connector coupled with a proximal end of the ultrasound transmission member for coupling the ultrasound transmission member with a separate ultrasound generating device; and at least one heat absorbing member coupled with the ultrasound transmission member adjacent the sonic connector. In some embodiments, the heat absorbing member surrounds a portion of the ultrasound transmission member adjacent a distal end of the sonic connector. Optionally, the heat absorbing member includes a bore for receiving the ultrasound transmission member. In some embodiments, such a heat absorbing member is tubular.
In some embodiments, the heat absorbing member contacts a distal end of the sonic connector, while in other embodiments the heat absorbing member may be separated from a distal end of the sonic connector by a distance of a few millimeters. The heat absorbing member may comprise one piece or, in other embodiments, the heat absorbing member may comprise at least two component parts such as at least one absorptive part in contact with the transmission member for absorbing heat and at least one constraining part coupled with the absorptive part for holding the absorptive part in place on the transmission member. In some such embodiments, the constraining part contacts the transmission member and comprises at least one absorptive material for absorbing heat. In various embodiments, the constraining part may either contact a portion of the sonic connector or overlap a portion of the sonic connector. Optionally, at least one of the absorptive part and the constraining part may be capable of absorbing vibrations. In some embodiments, the constraining part comprises a bore for receiving the ultrasound transmission wire, wherein the bore includes a widened portion for receiving the absorptive part. In some embodiments, the constraining part is tubular. Also in some embodiments, the constraining part is coupled with at least one of the absorptive part and the ultrasound transmission wire by at least one of crimping, bonding, fusing or welding.
In other embodiments, the heat absorbing member comprises at least two component parts comprising at least one vibration absorptive part in contact with the transmission member for absorbing vibrations and at least one constraining part coupled with the absorptive part for holding the absorptive part in place on the transmission member and for absorbing heat. In some embodiments, the constraining part contacts a portion of the sonic connector, while in other embodiments it overlaps a portion of the sonic connector. In some embodiments, the constraining part comprises a bore for receiving the ultrasound transmission wire, wherein the bore includes a widened portion for receiving the absorptive part. In such embodiments, the constraining part may sometimes be tubular.
In some embodiments, the heat absorbing member is capable of absorbing vibrations. In other embodiments, the ultrasound catheter further includes a vibrational absorbing member coupled with the ultrasound transmission member for absorbing vibrations. In either case, the heat absorbing member may comprise at least one metal having heat conductivity properties. The metal(s) may include, but are not limited to, aluminum and its alloys, titanium and its alloys, and/or magnesium and its alloys. Finally, in some embodiments the heat absorbing member is coupled with the ultrasound transmission wire by at least one of crimping, bonding, fusing or welding.
In another aspect, an ultrasound catheter for disrupting occlusions in blood vessels includes: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body; a sonic connector coupled with a proximal end of the ultrasound transmission member for coupling the ultrasound transmission member with a separate ultrasound generating device; and at least one vibration absorbing member coupled with the ultrasound transmission member adjacent the sonic connector. Any of the features and combinations described for the embodiments above may be equally applied to this aspect of the invention.
In some embodiments, the vibration absorbing member surrounds a portion of the ultrasound transmission member adjacent a distal end of the sonic connector. For example, the vibration absorbing member may include a bore for receiving the ultrasound transmission member. In some embodiments, the vibration absorbing member is tubular. In some embodiments, the vibration absorbing member contacts a distal end of the sonic connector, while in others it is separated from a distal end of the sonic connector by a distance of a few millimeters. For example, in some embodiments, the absorbing member may be separated from the sonic connector by approximately ¼ of a wavelength produced by the ultrasound device.
In some embodiments, the vibration absorbing member comprises at least two component parts, the component parts comprising: at least one absorptive part in contact with the transmission member for absorbing vibrations; and at least one constraining part coupled with the absorptive part for holding the absorptive part in place on the transmission member. In some embodiments, the at least one constraining part contacts the transmission member and comprises at least one absorptive material for absorbing heat. Also in some embodiments, the at least one constraining part contacts or overlaps a portion of the sonic connector. In some embodiments, at least one of the absorptive part and the constraining part is capable of absorbing heat. In some embodiments, the at least one constraining part comprises a bore for receiving the ultrasound transmission wire, wherein the bore includes a widened portion for receiving the absorptive part. In such embodiments, the constraining part may be tubular. The constraining part may be coupled with at least one of the absorptive part and the ultrasound transmission wire by at least one of crimping, bonding, fusing or welding.
In other embodiments, the vibration absorbing member comprises at least two component parts, the component parts comprising: at least one vibration absorptive part in contact with the transmission member for absorbing vibrations; and at least one constraining part coupled with the absorptive part for holding the absorptive part in place on the transmission member and for absorbing heat. The at least one constraining part may contact or overlap a portion of the sonic connector in various embodiments. Optionally, the constraining part may include a bore for receiving the ultrasound transmission wire, wherein the bore includes a widened portion for receiving the absorptive part. In such embodiments, the constraining part may be tubular, for example.
In some embodiments, the vibration absorbing member is capable of absorbing heat. In other embodiments, the ultrasound catheter further includes a heat absorbing member coupled with the ultrasound transmission member for absorbing heat. In some embodiments the vibration absorbing member comprises at least one vibration absorbing material selected from the group consisting of rubbers and polymers. In some embodiments, the vibration absorbing member further comprises at least one metal having heat conductivity properties. For example, such a metal may be selected from the group consisting of aluminum, titanium, and magnesium. In some embodiments, the vibration absorbing member is coupled with the ultrasound transmission wire by at least one of crimping, bonding, fusing or welding.
Ultrasound catheter devices and methods of the present invention generally provide for ablation and/or disruption of vascular occlusions. An ultrasound transmission member, such as a wire, transmits vibrational energy from an ultrasound transducer to a distal head of the catheter to disrupt vascular occlusions. At least one absorber member is disposed on or around the ultrasound transmission wire at a location adjacent the sonic connector of the catheter. The absorber member absorbs heat, vibrations, and/or the like from the ultrasound transmission wire at or near the area where the transmission wire is coupled with the sonic connector. The absorptive function typically slows the process of wear and tear on the transmission wire, thus extending the useful life of the ultrasound catheter. Although catheters of the invention are described in detail below, for further details reference may be made to U.S. patent application Ser. No. 10/229,371, filed Aug. 26, 2002, which was previously incorporated by reference.
Referring now to
Ultrasound catheters 10 of the present invention may be used with any suitable combination of devices, such as any suitable ultrasound transducer 14, ultrasound generator 16, and/or the like. Therefore, exemplary
Referring now to
In most embodiments, ultrasound transmission member 24, wire, or wave guide extends longitudinally through catheter body lumen 21 to transmit ultrasonic energy from ultrasound transducer 14, connected to the proximal end of catheter 10, to the distal end of catheter 10. Ultrasound transmission member 24 may be formed of any material capable of effectively transmitting ultrasonic energy from ultrasound transducer 14 to the distal end of catheter body 22, including but not limited to metals such as pure titanium or aluminum, or titanium or aluminum alloys.
In accordance with one aspect of the invention, all or a portion of ultrasound transmission member 24 may be formed of one or more materials which exhibit superelastic properties. Such material(s) should preferably exhibit superelasticity consistently within the range of temperatures normally encountered by ultrasound transmission member 24 during operation of ultrasound catheter apparatus 10. Specifically, all or part of the ultrasound transmission member 24 may be formed of one or more metal alloys known as “shape memory alloys.”
Use of superelastic metal alloys in ultrasound transmission members is described in U.S. Pat. No. 5,267,954, previously incorporated by reference. Examples of superelastic metal alloys which may be used are described in detail in U.S. Pat. Nos. 4,665,906 (Jervis); 4,565,589 (Harrison); 4,505,767 (Quin); and 4,337,090 (Harrison). The disclosures of U.S. Pat. Nos. 4,665,906; 4,565,589; 4,505,767; and 4,337,090 are expressly incorporated herein by reference insofar as they describe the compositions, properties, chemistries and behavior of specific metal alloys which are superelastic within the temperature range at which the ultrasound transmission member of the present invention operates, any and all of which superelastic metal alloys may be used to form ultrasound transmission member 24 of the present invention.
In many embodiments, ultrasound transmission member 24 includes one or more tapered regions along a portion of its length, towards its distal end. Such a tapered region decreases the distal rigidity of ultrasound transmission member 24, thus amplifying ultrasound energy transmitted along ultrasound transmission member 24 to distal head 26. The tapered region typically divides the transmission member 24 between a proximal portion and a distal portion, which both typically have a larger cross-sectional diameter than the tapered region. A thicker distal portion, for example, may enhance stability of the connection between ultrasound transmission member 24 and distal head 26. Other embodiments are contemplated, however. For example, the tapered region may be positioned at the extreme distal end of transmission member 24. In still other embodiments, ultrasound transmission member 24 may include multiple tapered portions, widened portions and/or the like. Thus, ultrasound transmission member 24 may be configured with any suitable length, combinations of diameters and tapers, or any other suitable shapes, sizes or configurations to advantageously transmit ultrasound energy from transducer 14 to distal tip 26.
In some embodiments ultrasound transmission member 24 may include a low-friction coating or jacket on all or a portion of its outer surface. The coating may be disposed on the outer surface of ultrasound transmission member 24 so as to completely cover ultrasound transmission member 24 along its entire length, or along a discrete region or regions thereof. Such a coating or jacket may comprise a layer of low friction polymer material such as polytetrafluoroethylene (PTFE), TEFLON™ (available from D
With continued reference to
Middle segment 45 of bore 44, in some embodiments, may surround a portion of sonic connector 52, while in other embodiments, sonic connector 52 may be housed only within proximal segment 47. Sonic connector 48 is coupled with the distal end of ultrasound transmission member 24 by any suitable means for transmitting ultrasound energy to transmission member 24 from transducer 14. An absorber member 50 is disposed around at least a portion of ultrasound transmission member 24 immediately distal and immediately adjacent to sonic connector 52. Absorber member 50 is described in further detail below, but generally is configured to abut sonic connector 52 to absorb heat and/or transverse vibrations from, and therefore reduce wear and tear on, ultrasound transmission member 24. Optionally, some embodiments further include one or more O-rings 46 distal to absorber member 50 and disposed about ultrasound transmission member 24 for providing further absorption of transverse vibration. Absorber member 50 and O-rings 46 may be used in any number or combination and have and suitable size and configuration, depending on the desired level of vibration absorption or dampening. Alternatively or additionally, other dampening structures may be used. Thus, the invention is not limited to the combination shown in
Distal segment 49 of bore 44 typically surrounds a portion of ultrasound transmission member 24 and may also contain one or more additional sets of absorber members 46. Distal segment 49 may also contain a portion of a Y-connector 15, which is coupled with the distal end 43 of housing 42 of proximal end connector apparatus 12. Coupling of Y-connector 15 with distal end 43 of proximal end connector assembly 12 may be accomplished via complementary threads, pressure fitting, or any other suitable means. A Y-connector lumen 48 of Y-connector 15 allows passage of ultrasound transmission member 24 and is in communication with the catheter body lumen.
Generally, pressurized fluid such as a coolant liquid may be infused through side-arm 13, through Y-connector lumen 45 and through the catheter body lumen so that it flows out of one or more fluid outflow apertures in distal head. The temperature and flow rate of such coolant liquid may be specifically controlled to maintain the temperature of ultrasound transmission member 24 at a desired temperature within its optimal working range. In particular, in embodiments of the invention wherein ultrasound transmission member 24 is formed of a metal alloy which exhibits optimal physical properties (e.g. super elasticity) within a specific range of temperatures, the temperature and flow rate of coolant liquid infused through fluid infusion side-arm 13 may be specifically controlled to maintain the temperature of ultrasound transmission member 24 within a range of temperatures at which it demonstrates its most desirable physical properties. For example, in embodiments of the invention wherein ultrasound transmission member 24 is formed of a shape memory alloy which exhibits super elasticity when in its martensite state, but which loses super elasticity as it transitions to an austenite state, it will be desirable to adjust the temperature and flow rate of the coolant liquid infused through fluid infusion side-arm 13 so as to maintain the shape memory alloy of ultrasound transmission member 24 within a temperature range at which the alloy will remain in its martensite state and will not transition to an austenite state. The temperature at which such shape memory alloys transition from a martensite state to an austenite state is known as the “martensite transition temperature” of the material. Thus, in these embodiments, the fluid infused through side-arm 13 will be at such temperature, and will be infused at such rate, as to maintain the shape memory alloy of ultrasound transmission member 24 below its martensite transition temperature.
Referring to
Absorber member 50 may be coupled with ultrasound transmission member 24 by any suitable means. In some embodiments, for example, absorber member 50 may be positioned at a desired location on transmission member 24 during manufacturing and then may be crimped, using a crimping device, to adhere to transmission member 24. Other methods for coupling absorber member 50 with transmission member 24 are also contemplated, such as pressure fitting, use of adhesive substances, and the like.
Absorber members 50 of the present invention are generally positioned on transmission member 24 at a location adjacent to the distal end of sonic connector 52. As shown in
With reference now to
In other embodiments, for example as in
Referring now to
Although the invention has been described above with specific reference to various embodiments and examples, it should be understood that various additions, modifications, deletions and alterations may be made to such embodiments without departing from the spirit or scope of the invention. Accordingly, it is intended that all reasonably foreseeable additions, deletions, alterations and modifications be included within the scope of the invention as defined in the following claims.
This application is a continuation of U.S. patent application Ser. No. 11/179,829 (now U.S. Pat. No. 7,621,929), filed Jul. 11 , 2005, which is a division of U.S. patent application Ser. No. 10/375,903 (now U.S. Pat. No. 6,942,677), filed Feb. 26, 2003, and is related to U.S. patent application Ser. No. 10/229,371 (now U.S. Pat. No. 7,137,963), filed Aug. 26, 2002, entitled “Ultrasound Catheter for Disrupting Blood Vessel Obstructions,” the full disclosures of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
3433226 | Boyd | Mar 1969 | A |
3565062 | Kuris | Feb 1971 | A |
3612038 | Halligan et al. | Oct 1971 | A |
3631848 | Muller | Jan 1972 | A |
3719737 | Vaillancourt et al. | Mar 1973 | A |
3823717 | Pohlman et al. | Jul 1974 | A |
3839841 | Amplatz | Oct 1974 | A |
3896811 | Storz | Jul 1975 | A |
4016882 | Broadwin et al. | Apr 1977 | A |
4033331 | Guss et al. | Jul 1977 | A |
4136700 | Broadwin et al. | Jan 1979 | A |
4337090 | Harrison | Jun 1982 | A |
4368410 | Hance | Jan 1983 | A |
4417578 | Banko | Nov 1983 | A |
4425115 | Wuchinich | Jan 1984 | A |
4486680 | Bonnet et al. | Dec 1984 | A |
4505767 | Quin | Mar 1985 | A |
4565589 | Harrison | Jan 1986 | A |
4572184 | Stohl et al. | Feb 1986 | A |
4664112 | Kensey et al. | May 1987 | A |
4665906 | Jervis | May 1987 | A |
4679558 | Kensey et al. | Jul 1987 | A |
4700705 | Kensey et al. | Oct 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4750902 | Wuchinich et al. | Jun 1988 | A |
4808153 | Parisi | Feb 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4827911 | Broadwin et al. | May 1989 | A |
4838853 | Parisi | Jun 1989 | A |
4854325 | Stevens | Aug 1989 | A |
4870953 | DonMicheal et al. | Oct 1989 | A |
4886060 | Wiksell | Dec 1989 | A |
4920954 | Alliger et al. | May 1990 | A |
4923462 | Stevens | May 1990 | A |
4924863 | Sterzer | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4936845 | Stevens | Jun 1990 | A |
5000185 | Yock | Mar 1991 | A |
5015227 | Broadwin et al. | May 1991 | A |
5026384 | Farr et al. | Jun 1991 | A |
5046503 | Schneiderman | Sep 1991 | A |
5053008 | Bajaj | Oct 1991 | A |
5058570 | Idemoto et al. | Oct 1991 | A |
5076276 | Sakurai | Dec 1991 | A |
5091205 | Fan | Feb 1992 | A |
5100423 | Fearnot | Mar 1992 | A |
5109859 | Jenkins | May 1992 | A |
5114414 | Buchbinder | May 1992 | A |
5116350 | Stevens | May 1992 | A |
5127917 | Niederhauser et al. | Jul 1992 | A |
5156143 | Bocquet et al. | Oct 1992 | A |
5163421 | Bernstein | Nov 1992 | A |
5180363 | Idemoto et al. | Jan 1993 | A |
5183470 | Wettermann | Feb 1993 | A |
5195955 | Don Michael | Mar 1993 | A |
5215614 | Wijkamp et al. | Jun 1993 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5226421 | Frisbie et al. | Jul 1993 | A |
5234416 | Macaulay et al. | Aug 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242385 | Strukel | Sep 1993 | A |
5243997 | Uflacker et al. | Sep 1993 | A |
5248296 | Alliger | Sep 1993 | A |
5255669 | Kubota et al. | Oct 1993 | A |
5267954 | Nita | Dec 1993 | A |
5269291 | Carter | Dec 1993 | A |
5269297 | Weng et al. | Dec 1993 | A |
5269793 | Simpson | Dec 1993 | A |
5287858 | Hammerslag et al. | Feb 1994 | A |
5290229 | Paskar | Mar 1994 | A |
5304115 | Pflueger et al. | Apr 1994 | A |
5304131 | Paskar | Apr 1994 | A |
5312328 | Nita et al. | May 1994 | A |
5324255 | Passafaro et al. | Jun 1994 | A |
5324260 | O'neill et al. | Jun 1994 | A |
5325860 | Seward et al. | Jul 1994 | A |
5326342 | Pflueger et al. | Jul 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5342292 | Nita et al. | Aug 1994 | A |
5344395 | Whalen et al. | Sep 1994 | A |
5346502 | Estabrook et al. | Sep 1994 | A |
5362309 | Carter | Nov 1994 | A |
5368557 | Nita | Nov 1994 | A |
5368558 | Nita | Nov 1994 | A |
5376084 | Bacich et al. | Dec 1994 | A |
5378234 | Hammerslag et al. | Jan 1995 | A |
5380274 | Nita | Jan 1995 | A |
5380316 | Aita et al. | Jan 1995 | A |
5382228 | Nita et al. | Jan 1995 | A |
5383460 | Jang et al. | Jan 1995 | A |
5389096 | Aita et al. | Feb 1995 | A |
5397293 | Alliger et al. | Mar 1995 | A |
5397301 | Pflueger et al. | Mar 1995 | A |
5405318 | Nita | Apr 1995 | A |
5409483 | Campbell et al. | Apr 1995 | A |
5417672 | Nita et al. | May 1995 | A |
5417703 | Brown et al. | May 1995 | A |
5427118 | Nita et al. | Jun 1995 | A |
5431168 | Webster, Jr. | Jul 1995 | A |
5431663 | Carter | Jul 1995 | A |
5443078 | Uflacker | Aug 1995 | A |
5447509 | Mills et al. | Sep 1995 | A |
5449369 | Imran | Sep 1995 | A |
5451209 | Ainsworth et al. | Sep 1995 | A |
5465733 | Hinohara et al. | Nov 1995 | A |
5474531 | Carter | Dec 1995 | A |
5480379 | La Rosa | Jan 1996 | A |
5484398 | Stoddard | Jan 1996 | A |
5487757 | Truckai et al. | Jan 1996 | A |
5507738 | Ciervo | Apr 1996 | A |
5516043 | Manna et al. | May 1996 | A |
5527273 | Manna et al. | Jun 1996 | A |
5540656 | Pflueger et al. | Jul 1996 | A |
5542917 | Nita et al. | Aug 1996 | A |
5597882 | Schiller et al. | Jan 1997 | A |
5607421 | Jeevanandam et al. | Mar 1997 | A |
5611807 | O'Boyle | Mar 1997 | A |
5618266 | Liprie | Apr 1997 | A |
5626593 | Imran | May 1997 | A |
5658282 | Daw et al. | Aug 1997 | A |
5695460 | Siegel et al. | Dec 1997 | A |
5695507 | Auth et al. | Dec 1997 | A |
5715825 | Crowley | Feb 1998 | A |
5720724 | Ressemann et al. | Feb 1998 | A |
5728062 | Brisken | Mar 1998 | A |
5738100 | Yagami et al. | Apr 1998 | A |
5797876 | Spears et al. | Aug 1998 | A |
5816923 | Milo et al. | Oct 1998 | A |
5827203 | Nita | Oct 1998 | A |
5830222 | Makower | Nov 1998 | A |
5846218 | Brisken et al. | Dec 1998 | A |
5895397 | Jang et al. | Apr 1999 | A |
5902287 | Martin | May 1999 | A |
5904667 | Falwell | May 1999 | A |
5916192 | Nita et al. | Jun 1999 | A |
5935142 | Hood | Aug 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957899 | Spears et al. | Sep 1999 | A |
5964223 | Baran | Oct 1999 | A |
5967984 | Chu et al. | Oct 1999 | A |
5971949 | Levin et al. | Oct 1999 | A |
5976119 | Spears et al. | Nov 1999 | A |
5989208 | Nita | Nov 1999 | A |
5997497 | Nita et al. | Dec 1999 | A |
6004280 | Buck et al. | Dec 1999 | A |
6007499 | Martin et al. | Dec 1999 | A |
6007514 | Nita | Dec 1999 | A |
6022309 | Celliers et al. | Feb 2000 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6030357 | Daoud et al. | Feb 2000 | A |
6051010 | DiMatteo et al. | Apr 2000 | A |
6113558 | Rosenschein et al. | Sep 2000 | A |
6123698 | Spears et al. | Sep 2000 | A |
6149596 | Bancroft | Nov 2000 | A |
6159176 | Broadwin et al. | Dec 2000 | A |
6165127 | Crowley | Dec 2000 | A |
6165188 | Saadat et al. | Dec 2000 | A |
6179809 | Khairkhahan et al. | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6206842 | Tu et al. | Mar 2001 | B1 |
6210356 | Anderson et al. | Apr 2001 | B1 |
6217543 | Anis et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6235007 | Divinio, Jr. et al. | May 2001 | B1 |
6241692 | Tu et al. | Jun 2001 | B1 |
6241703 | Levin et al. | Jun 2001 | B1 |
6277084 | Abele et al. | Aug 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6287271 | Dubrul et al. | Sep 2001 | B1 |
6287285 | Michal et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6296620 | Gesswein et al. | Oct 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6309358 | Okubo | Oct 2001 | B1 |
6315741 | Martin et al. | Nov 2001 | B1 |
6331171 | Cohen | Dec 2001 | B1 |
6379378 | Werneth et al. | Apr 2002 | B1 |
6387109 | Davison et al. | May 2002 | B1 |
6394956 | Chandrasekaran et al. | May 2002 | B1 |
6398736 | Seward | Jun 2002 | B1 |
6416533 | Gobin et al. | Jul 2002 | B1 |
6423026 | Gesswein et al. | Jul 2002 | B1 |
6433464 | Jones | Aug 2002 | B2 |
6434418 | Neal et al. | Aug 2002 | B1 |
6450975 | Brennan et al. | Sep 2002 | B1 |
6454757 | Nita et al. | Sep 2002 | B1 |
6454997 | Divino, Jr. et al. | Sep 2002 | B1 |
6484052 | Visuri et al. | Nov 2002 | B1 |
6491707 | Makower | Dec 2002 | B2 |
6494891 | Cornish et al. | Dec 2002 | B1 |
6508781 | Brennan et al. | Jan 2003 | B1 |
6508784 | Shu | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6544215 | Bencini et al. | Apr 2003 | B1 |
6547754 | Evans et al. | Apr 2003 | B1 |
6551337 | Rabiner et al. | Apr 2003 | B1 |
6554846 | Hamilton et al. | Apr 2003 | B2 |
6558502 | Divino, Jr. et al. | May 2003 | B2 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6589253 | Cornish et al. | Jul 2003 | B1 |
6596235 | Divino, Jr. et al. | Jul 2003 | B2 |
6615062 | Ryan et al. | Sep 2003 | B2 |
6623448 | Slater | Sep 2003 | B2 |
6635017 | Moehring et al. | Oct 2003 | B1 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6660013 | Rabiner | Dec 2003 | B2 |
6676900 | Divino, Jr. et al. | Jan 2004 | B1 |
6682502 | Bond et al. | Jan 2004 | B2 |
6685657 | Jones | Feb 2004 | B2 |
6689086 | Nita et al. | Feb 2004 | B1 |
6695781 | Rabiner et al. | Feb 2004 | B2 |
6695782 | Ranucci et al. | Feb 2004 | B2 |
6702750 | Yock | Mar 2004 | B2 |
6719725 | Milo et al. | Apr 2004 | B2 |
6729334 | Baran | May 2004 | B1 |
6761698 | Shibata et al. | Jul 2004 | B2 |
6855123 | Nita | Feb 2005 | B2 |
6936025 | Evans et al. | Aug 2005 | B1 |
6936056 | Nash et al. | Aug 2005 | B2 |
6942677 | Nita et al. | Sep 2005 | B2 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7056294 | Khairkhahan et al. | Jun 2006 | B2 |
7131983 | Murakami | Nov 2006 | B2 |
7137963 | Nita et al. | Nov 2006 | B2 |
7150853 | Lee et al. | Dec 2006 | B2 |
7166098 | Steward et al. | Jan 2007 | B1 |
7267650 | Chow et al. | Sep 2007 | B2 |
7335180 | Nita et al. | Feb 2008 | B2 |
7384407 | Rodriguez et al. | Jun 2008 | B2 |
7494468 | Rabiner et al. | Feb 2009 | B2 |
7503895 | Rabiner et al. | Mar 2009 | B2 |
7604608 | Nita et al. | Oct 2009 | B2 |
7621929 | Nita et al. | Nov 2009 | B2 |
7776025 | Bobo, Jr. | Aug 2010 | B2 |
7938819 | Kugler et al. | May 2011 | B2 |
8083727 | Kugler et al. | Dec 2011 | B2 |
8133236 | Nita | Mar 2012 | B2 |
8226566 | Nita | Jul 2012 | B2 |
20020049402 | Peacock, III et al. | Apr 2002 | A1 |
20030009153 | Brisken et al. | Jan 2003 | A1 |
20030036705 | Hare et al. | Feb 2003 | A1 |
20030125620 | Satou et al. | Jul 2003 | A1 |
20030199817 | Thompson et al. | Oct 2003 | A1 |
20050222557 | Baxter et al. | Oct 2005 | A1 |
20060264759 | Moehring et al. | Nov 2006 | A1 |
20070037119 | Pal et al. | Feb 2007 | A1 |
20070260172 | Nita | Nov 2007 | A1 |
20080287804 | Nita | Nov 2008 | A1 |
20110130834 | Wilson et al. | Jun 2011 | A1 |
Number | Date | Country |
---|---|---|
2256127 | May 1974 | DE |
3821836 | Feb 1976 | DE |
2438648 | Jan 1990 | DE |
8910040 | Jan 1990 | DE |
4042435 | Aug 1991 | DE |
0005719 | Dec 1979 | EP |
316789 | May 1989 | EP |
316789 | May 1989 | EP |
0376562 | Jul 1990 | EP |
0379156 | Jul 1990 | EP |
0394583 | Oct 1990 | EP |
0443256 | Aug 1991 | EP |
0541249 | May 1993 | EP |
0820728 | Jan 1998 | EP |
1323481 | Jul 2003 | EP |
1106957 | Mar 1968 | GB |
SHO61-272045 | Dec 1986 | JP |
01099547 | Apr 1989 | JP |
2-71510 | May 1990 | JP |
U03067608 | Jul 1991 | JP |
2006086822 | Mar 1994 | JP |
2007116260 | May 1995 | JP |
09-503137 | Mar 1997 | JP |
10216140 | Aug 1998 | JP |
2001104356 | Apr 2001 | JP |
2001321388 | Nov 2001 | JP |
2002186627 | Jul 2002 | JP |
2005-253874 | Sep 2005 | JP |
2006-522644 | Oct 2006 | JP |
WO 8705739 | Sep 1987 | WO |
WO 8906515 | Sep 1989 | WO |
WO 9001300 | Feb 1990 | WO |
WO9004362 | May 1990 | WO |
WO9107917 | Jun 1991 | WO |
WO9211815 | Jul 1992 | WO |
WO9308750 | May 1993 | WO |
WO9316646 | Sep 1993 | WO |
WO9412140 | Jun 1994 | WO |
WO9414382 | Jul 1994 | WO |
WO9508954 | Apr 1995 | WO |
WO9509571 | Apr 1995 | WO |
WO 9515192 | Jun 1995 | WO |
WO9635469 | Nov 1996 | WO |
WO 9721462 | Jun 1997 | WO |
WO 9745078 | Dec 1997 | WO |
WO9835721 | Aug 1998 | WO |
WO9852637 | Nov 1998 | WO |
WO9925412 | May 1999 | WO |
WO0053341 | Sep 2000 | WO |
WO0067830 | Nov 2000 | WO |
WO2004012609 | Feb 2004 | WO |
WO 2004093736 | Nov 2004 | WO |
WO2004112888 | Dec 2004 | WO |
WO 2005053769 | Jun 2005 | WO |
WO 2006049593 | May 2006 | WO |
Entry |
---|
“E-Beam Theory” RDI-IBA Technology Group, downloaded from web on Oct. 8, 2002 <http://www.e-beam-rd/Ebeam Theory.htm> 2 pages total. |
“What is electron beam curing?” downloaded from web on Nov. 14, 2002 <http://www.mis.omi.gov/researchgroups/composites/new%20orccmt%20pages/pages/ebwha> 4 pages total. |
Calhoun, et al., “Electron-beam systems for medical device sterilization” download from web on Oct. 8, 2002 <http://www.devicelink.com/mpb/archives/97/07/002.html> 7 pages total. |
Siegel, et al., “In Vivo Ultrasound Arterial Recanalization of Atherosclerotic Total Occlusions”, Journal of the American College of Cardiology, Feb. 1990, vol. 15, No. 2, pp. 345-351. |
Extended European Search Report dated Mar. 5, 2012 for European Application No. 12153606.4. |
Office Action for Japanese Patent Application No. 2010-122862, Mar. 5, 2012. |
Health Care Without Harm [report], Non-Incineration Medical Waste Treatment Technologies, “Irradiation, biological, and other technologies: E-beam, biological, and sharps treatment systems”, Chapter 9., Aug. 2001, pp. 69-74. |
Chandra Sehgal et al., Ultrasound-Assisted Thrombolysis, Investigative Radiology, 1993, vol. 28, Issue 10, pp. 939-943. |
http://www.merriam-webster.com/dictionary/couple, definition of the term coupled retrieved on, May 18, 2013. |
Margaret Fyfe et al., Mast cell degranulation and increased vascular permeability induced by ‘therapeutic’ ultrasound in the rate ankle joint, Br. J. exp. Path., 1984, vol. 65, pp. 671-676. |
Number | Date | Country | |
---|---|---|---|
20100049209 A1 | Feb 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10375903 | Feb 2003 | US |
Child | 11179829 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11179829 | Jul 2005 | US |
Child | 12572118 | US |